ALERT: Globe Advisor Client Management Changes
Client Center will be decommissioned December 31, 2018. Read More

BAUSCH HEALTH COMPANIES INC.

BAUSCH HEALTH COMPANIES INC. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The company is focused on the development and commercialization of medicines that address unmet medical needs in specialty CNS markets.


Find Out More
 • Chart
 • News
 • Stock today
 • Price Reports
 • Financial Reports
 • Price History
 • Estimate Reports
 • Estimate Snapshot
 • Add To Your Stocklist
 • View your Stocklist
Click here to print this page.
Symbol: BHC
Exchange(s): New York Stock Exchange, Toronto Stock Exchange
Industry: Consumer Products (Biotechnology & Pharmaceuticals)
5-Star Rating:
ANNUAL FINANCIALS
  Dec 31, 2017
12 Months
us$
Dec 31, 2016
12 Months
us$
Dec 31, 2015
12 Months
us$
3Yr.
Growth
% Change
Total Revenue ($000) 9,196,000 9,682,000 10,443,000 7.23
Earnings before Interest & Tax ($000) -68,000 -599,000 1,408,000 N/A
Profit/Loss ($000) 2,404,000 -2,409,000 -292,000 47.52
Earnings per Share 6.86 -6.94 -0.85 37.65
Total Assets ($000) 37,497,000 43,529,000 48,965,000 16.43
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity 52.25 -51.88 -5.11  
Employees 20,700 21,500 22,000  
 
Trailing 12 Month Results
  12 Months ended
Sep 30, 2018, us$
12 Months ended
Sep 30, 2017, us$
%Change
Total Revenue ($000) 8,496,000 9,321,000 -8.85
Profit/Loss ($000) -3,403,000 1,376,000 -347.31
Earnings per Share -9.71 3.93 -347.07
Dividends Per Share 0.00 0.00
Number of Shares 349,754,139 348,582,556  
 
COMPANY INFORMATION
Report on Business Magazine Top 1000 Ranking
Profit: 0010 Revenue: 0038 Assets:  0021  
 
Key Personnel
CEO: J. Michael Pearson, Chairman & C.E.O.
CFO: Howard B. Schiller, E.V.P. & C.F.O.
HR: Brian Stolz, E.V.P. of Administration & CHC
 
Contact Information
Address: 2150 St. Elzear Blvd. West,
Laval,
QC,
H7L 4A8
Phone: 514-744-6792
Fax: 514-744-6272
Web Address: www.valeant.com
E-Mail : ir@valeant.com
Investor Relations: Howard B. Schiller, 949-461-6002
 
Company Type: Public Company Status: Active
Auditors: Ernst & Young Llp
Transfer Agent: Ast Trust Company Toronto
Incorporation: Ontario 
 
Securities: BHC-N BHC-T
 
Top Companies in Biotechnology & Pharmaceuticals (Selected by Assets)
Concordia International (D) Aurora Cannabis Inc. Knight Therapeutics
Jamieson Wellness GDI Integrated Facility Serv. Aralez Pharmaceuticals Inc.
ProMetic Life Sciences The Supreme Cannabis Company CRH Medical
 


All information on this site is compiled by The Globe and Mail Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, The Globe and Mail Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.

Copyright © 2019 The Globe and Mail Inc. All rights reserved.


<